ACUTUS MEDICAL INC (AFIB) Stock Analyst Earnings Estimates
NASDAQ:AFIB - Nasdaq - US0051111096 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.26M 104.02% | 16.36M -5.21% | 7.164M -56.21% | 32.489M 353.50% | 50.445M 55.27% | 100.81M 99.84% | 165.79M 64.46% | 180.23M 8.71% | 207.47M 15.11% | 234.7M 13.12% | |
| EBITDA YoY % growth | -105.73M -20.00% | -85.93M 18.73% | -20.617M 76.01% | -55.692M -170.13% | -46.818M 15.93% | -23.154M 50.54% | 3.264M 114.10% | 35.216M 978.92% | 60.741M 72.48% | 76.067M 25.23% | |
| EBIT YoY % growth | -112.12M -22.76% | -92.41M 17.58% | -20.808M 77.48% | -63.597M -205.64% | -55.743M 12.35% | -37.128M 33.39% | -13.566M 63.46% | 7.676M 156.58% | 33.201M 332.53% | 48.527M 46.16% | |
| Operating Margin | -649.59% | -564.85% | -290.45% | -195.75% | -110.50% | -36.83% | -8.18% | 4.26% | 16.00% | 20.68% | |
| EPS YoY % growth | -4.12 75.43% | -2.69 34.71% | N/A 12.16% | -1.81 23.31% | -1.43 21.20% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.45 29.30% | -0.44 1.78% | -0.44 19.37% |
| Revenue Q2Q % growth | 7.782M 47.14% | 8.418M 60.71% | 9.689M 35.25% |
| EBITDA Q2Q % growth | -14.076M 13.16% | -13.617M -14.08% | -13.719M 33.46% |
| EBIT Q2Q % growth | -16.065M 14.46% | -15.555M 0.19% | -15.708M 24.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.07 87.72% | -0.50 | 0.43 | 86.09% |
| Q4 2023 Q2Q % growth | -232.68% | -0.54 | % | |
| Q3 2023 Q2Q % growth | -0.45 37.50% | -0.62 | 0.17 | 27.28% |
| Q2 2023 Q2Q % growth | -0.63 54.35% | -0.65 | 0.02 | 3.49% |
| Q1 2023 Q2Q % growth | -0.57 43.00% | -0.70 | 0.13 | 19.01% |
| Q4 2022 Q2Q % growth | 0.41 136.61% | -0.72 | 1.13 | 156.88% |
| Q3 2022 Q2Q % growth | -0.72 23.40% | -0.82 | 0.10 | 12.64% |
| Q2 2022 Q2Q % growth | -1.38 -35.29% | -0.81 | -0.57 | -69.97% |
| Q1 2022 Q2Q % growth | -1.00 3.85% | -0.94 | -0.06 | -6.18% |
| Q4 2021 Q2Q % growth | -1.12 -6.67% | -0.85 | -0.27 | -31.50% |
| Q3 2021 Q2Q % growth | -0.94 51.79% | -0.88 | -0.06 | -6.33% |
| Q2 2021 Q2Q % growth | -1.02 96.84% | -0.85 | -0.17 | -19.33% |
| Q1 2021 Q2Q % growth | -1.04 | -0.83 | -0.21 | -25.57% |
| Q4 2020 Q2Q % growth | -1.05 | -0.74 | -0.31 | -42.58% |
| Q3 2020 Q2Q % growth | -1.95 | -1.01 | -0.94 | -92.72% |
| Q2 2020 Q2Q % growth | -32.24 | -1.05 | -31.19 | -2,968.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 3.63M -12.95% | 6.599M | -2.969M | -44.99% |
| Q4 2023 Q2Q % growth | 7.164M 44.44% | 6.64M | 524K | 7.89% |
| Q3 2023 Q2Q % growth | 5.238M 43.90% | 4.93M | 308K | 6.25% |
| Q2 2023 Q2Q % growth | 5.289M 29.63% | 4.619M | 670K | 14.51% |
| Q1 2023 Q2Q % growth | 4.17M 13.32% | 3.924M | 246K | 6.27% |
| Q4 2022 Q2Q % growth | 4.96M 13.76% | 4.402M | 558K | 12.68% |
| Q3 2022 Q2Q % growth | 3.64M -20.87% | 3.722M | -82K | -2.20% |
| Q2 2022 Q2Q % growth | 4.08M -13.38% | 3.913M | 167K | 4.27% |
| Q1 2022 Q2Q % growth | 3.68M 2.51% | 3.19M | 490K | 15.36% |
| Q4 2021 Q2Q % growth | 4.36M 69.65% | 4.3M | 60K | 1.40% |
| Q3 2021 Q2Q % growth | 4.6M 45.11% | 5.799M | -1.199M | -20.68% |
| Q2 2021 Q2Q % growth | 4.71M 316.81% | 4.433M | 277K | 6.25% |
| Q1 2021 Q2Q % growth | 3.59M 127.22% | 2.831M | 759K | 26.81% |
| Q4 2020 Q2Q % growth | 2.57M | 3.674M | -1.104M | -30.05% |
| Q3 2020 Q2Q % growth | 3.17M | 3.078M | 92K | 2.99% |
| Q2 2020 Q2Q % growth | 1.13M | 1.122M | 8K | 0.71% |
| Q1 2020 Q2Q % growth | 1.58M 100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |